These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23410147)

  • 1. Adding pancreatic panniculitis to the panel of skin lesions associated with triple therapy of chronic hepatitis C.
    Pfaundler N; Kessebohm K; Blum R; Stieger M; Stickel F
    Liver Int; 2013 Apr; 33(4):648-9. PubMed ID: 23410147
    [No Abstract]   [Full Text] [Related]  

  • 2. [Probable cutaneous sarcoidosis associated with combined ribavirin and interferon-alpha therapy for chronic hepatitis C].
    Savoye G; Goria O; Herve S; Riachi G; Noblesse I; Bastien L; Courville P; Lerebours E
    Gastroenterol Clin Biol; 2000; 24(6-7):679. PubMed ID: 10962394
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary: real-world triple therapy experience treating hepatitis C virus.
    Heron T; Miller MH; Dillon JF
    Aliment Pharmacol Ther; 2014 Mar; 39(5):542. PubMed ID: 24494841
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary: real-world triple therapy experience treating hepatitis C virus - authors' reply.
    Bichoupan K; Schwartz JM; Martel-Laferriere V; Giannattasio ER; Marfo K; Odin JA; Liu LU; Schiano TD; Perumalswami P; Bansal M; Gaglio PJ; Kalia H; Dieterich DT; Branch AD; Reinus JF
    Aliment Pharmacol Ther; 2014 Mar; 39(5):543. PubMed ID: 24494843
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of Myasthenia gravis due to treatment of chronic hepatitis C with a combination of interferon-alpha and ribavirin.
    Bektas M; Bektas H; Gören D; Altan M; Cetinkaya H
    Digestion; 2007; 75(4):208-9. PubMed ID: 17934275
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute pancreatitis associated with the use of peginterferon.
    Ozdogan O; Tahan V; Cincin A; Imeryuz N; Tozun N
    Pancreas; 2007 May; 34(4):485-7. PubMed ID: 17446854
    [No Abstract]   [Full Text] [Related]  

  • 7. [Onset of type 1 diabetes mellitus during combination therapy of chronic hepatitis C with interferon-alpha and ribavirin].
    Christensen UB; Krogsgaard K
    Ugeskr Laeger; 2004 Mar; 166(11):1024-5. PubMed ID: 15049242
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acute pancreatitis during treatment for chronic viral hepatitis C].
    Kabbaj N; Sentissi S; Guedira MM; Mohammadi M; Benaïssa A; Amrani N
    Gastroenterol Clin Biol; 2008 Mar; 32(3):232-3. PubMed ID: 18378105
    [No Abstract]   [Full Text] [Related]  

  • 9. Face skin hyperpigmentation during pegylated interferon and ribavirin therapy.
    Yaşar B; Yaşar Ş; Güneş P
    Turk J Gastroenterol; 2015 Mar; 26(2):189-90. PubMed ID: 25835121
    [No Abstract]   [Full Text] [Related]  

  • 10. [The influence of HCV infection and immunomodulating therapy (interferon-alpha and ribavirin) on the condition of minor salivary glands and oral mucosa].
    Sulka A; Simon K; Jeleń M; Piszko P
    Przegl Epidemiol; 2005; 59(2):455-66. PubMed ID: 16190554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interferon-alpha and ribavirin: advances in the therapy of chronic hepatitis C].
    Zeuzem S
    Dtsch Med Wochenschr; 1999 May; 124(20):636-42. PubMed ID: 10370387
    [No Abstract]   [Full Text] [Related]  

  • 12. Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders.
    Brillanti S; Foli M; Di Tomaso M; Gramantieri L; Masci C; Bolondi L
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):130-4. PubMed ID: 10363198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon plus ribavirin: a cautionary note.
    Macedo G; Ribeiro T
    Am J Gastroenterol; 1999 Oct; 94(10):3087-8. PubMed ID: 10520894
    [No Abstract]   [Full Text] [Related]  

  • 14. Diffuse cutaneous eruption due to interferon alfa and ribavirin treatment of chronic hepatitis C.
    Savk E; Uslu G; Karaoğlu AO; Sendur N; Karaman G
    J Eur Acad Dermatol Venereol; 2005 May; 19(3):396-8. PubMed ID: 15857485
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon-ribavirin-associated ischemic colitis.
    Punnam SR; Pothula VR; Gourineni N; Punnam A; Ranganathan V
    J Clin Gastroenterol; 2008 Mar; 42(3):323-5. PubMed ID: 18223489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open-safety study of dual antiviral therapy in real-world patients with chronic hepatitis C.
    Tinè F; Graviano D; Giannuoli G; Madonia S; Malizia G; Patti S; Fasola S; Cottone M; D'Amico G;
    Pharmacoepidemiol Drug Saf; 2010 Nov; 19(11):1113-23. PubMed ID: 20848397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of chronic hepatitis C].
    Bell H; Dalgard O; Bjøro K; Hellum KB; Myrvang B
    Tidsskr Nor Laegeforen; 2002 Apr; 122(9):926-8. PubMed ID: 12082838
    [No Abstract]   [Full Text] [Related]  

  • 18. Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.
    Hoofnagle JH; Ghany MG; Kleiner DE; Doo E; Heller T; Promrat K; Ong J; Khokhar F; Soza A; Herion D; Park Y; Everhart JE; Liang TJ
    Hepatology; 2003 Jul; 38(1):66-74. PubMed ID: 12829988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe anemia following combined alpha-interferon/ribavirin therapy of chronic hepatitis C.
    Tappero G; Ballaré M; Farina M; Negro F
    J Hepatol; 1998 Dec; 29(6):1033-4. PubMed ID: 9875657
    [No Abstract]   [Full Text] [Related]  

  • 20. Tongue hyperpigmentation during interferon-alpha and ribavirin therapy.
    Aguayo-Leiva I; Pérez B; Salguero I; Jaén P
    Eur J Dermatol; 2009; 19(3):291-2. PubMed ID: 19286489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.